Showing results out of
Researchers have come up with a way to test the efficacy of hundreds of anticancer drug combinations – simultaneously, rapidly, and accurately.
SCIENCE & TECHNOLOGY2022
sciencescience-technology
Bacterial cells are embedded in microfluidic droplets in oil. The fluorescence indicates the presence of the targeted DNA strain with the help of a characteristic DNA sequence.
SCIENCE & TECHNOLOGY2020
picture-of-the-weekscience-technology
Scientists hope that a legacy of the novel coronavirus in recovered COVID-19 patients – antibodies in their blood – could lead to drugs to treat others. The Merten group at EMBL Heidelberg has pivoted its microfluidics platform to support the search for neutralising antibodies that could…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Combinations of cancer drugs can be quickly and cheaply tested using a novel microfluidic device
SCIENCE & TECHNOLOGY2018
sciencescience-technology
New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies
LAB MATTERSSCIENCE & TECHNOLOGY2018
lab-mattersscience-technology
An EMBL collaboration devises a new method that could speed up vaccine development for HIV
SCIENCE & TECHNOLOGY2017
sciencescience-technology
Collaboration between scientists reveals collaboration between lipids.
SCIENCE & TECHNOLOGY2015
sciencescience-technology
EMBL scientists demonstrate that spatial constraints are a key factor in determining nucleus size.
SCIENCE & TECHNOLOGY2015
sciencescience-technology
No results found